NeuroPace Analyst Price Targets

Wall Street analyst price targets and consensus rating for NeuroPace (NPCE).

Price Target Range — 12 Quarters

Analyst Consensus — 8 Analysts

8Buy

Consensus RatingOverweight# Analysts8Avg. Consensus PT$18Upside to Avg. PT+19.1%

Rating Trend — Last 9 Months

Recent Analyst Actions

Date	Firm	Analyst	Action	Rating Change	Price Target
Jul 29, 2026	HC Wainwright & Co.	Yi Chen	Maintained	Buy	$20
Jul 23, 2026	Mizuho	Anthony Petrone	Initiate	Outperform	$22
May 15, 2026	HC Wainwright & Co.	Yi Chen	PT Raise	Buy	$19→$20
Jan 27, 2026	HC Wainwright & Co.	Yi Chen	PT Raise	Buy	$18→$19
Dec 16, 2025	UBS	Priya Sachdeva	PT Raise	Buy	$18→$22
Dec 10, 2025	JP Morgan	Rohin Patel	PT Raise	Overweight	$18→$20
Nov 5, 2025	JP Morgan	Rohin Patel	PT Raise	Overweight	$16→$18
Nov 5, 2025	Wells Fargo	Vik Chopra	PT Raise	Overweight	$15→$16
Aug 13, 2025	Wells Fargo	Vik Chopra	PT Cut	Overweight	$17→$15
May 28, 2025	HC Wainwright & Co.	Yi Chen	Initiate	Buy	$18
May 14, 2025	JP Morgan	Robbie Marcus	PT Raise	Overweight	$14→$16
May 14, 2025	Cantor Fitzgerald	Ross Osborn	Maintained	Overweight	$17
Apr 14, 2025	Cantor Fitzgerald	Ross Osborn	PT Cut	Overweight	$20→$17
Mar 5, 2025	Cantor Fitzgerald	Ross Osborn	PT Raise	Overweight	$19→$20
Jan 30, 2025	Wells Fargo	Larry Biegelsen	PT Raise	Overweight	$13→$17
Jan 21, 2025	UBS	Priya Sachdeva	Initiate	Buy	$17
Dec 17, 2024	JP Morgan	Robbie Marcus	PT Raise	Overweight	$9→$14
Nov 13, 2024	Wells Fargo	Vik Chopra	PT Cut	Overweight	$15→$13
Aug 14, 2024	Cantor Fitzgerald	Ross Osborn	Maintained	Overweight	$18
Aug 14, 2024	Wells Fargo	Vik Chopra	PT Cut	Overweight	$20→$15